Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC88A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100130468 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COLQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJB14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SMCR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC643733 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCHO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSDMB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF577 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129034 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on